The concluding piece in this Brain Tumor series spotlights the expertise of Dr. Gregory Riggins. A professor of Neurosurgery and Oncology, and Director of the Brain Cancer Biology and Therapy Research ...
In a study published in the journal Oncotarget on July 6, Gregory Riggins, M.D., Ph.D., professor of neurosurgery and oncology at the Johns Hopkins University School of Medicine, and his team used two ...
The concluding piece in this Brain Tumor series spotlights the expertise of Dr. Gregory Riggins. A professor of Neurosurgery and Oncology, and Director of the Brain Cancer Biology and Therapy Research ...
As the third-most lethal cancer in the United States, with only a 1% five-year survival rate for people with its most aggressive form, pancreatic cancer has long been a target of researchers who ...
Drugs that have been on the market for decades are being investigated for new uses. One is a medication used around the world to treat pinworm... A Pinworm Medication Is Being Tested As A Potential ...
Cancer researchers are testing whether a generic drug that has been used for more than 40 years to treat parasitic infections may also help fight cancer. The tests of mebendazole are part of a growing ...
Generic drugs used for other conditions are being given a second look as cancer treatments. (Katherine Streeter for NPR) Cancer researchers are testing whether a generic drug that has been used for ...
20170130_me_if_an_inexpensive_anti-parasitic_drug_fights_cancer_will_it_remain_affordable.mp3 Listen • 6:23 20170130_me_if_an_inexpensive_anti-parasitic_drug_fights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results